abstract |
The present invention relates to novel, biologically active and stabilized adrenomedullin (ADM) compounds. The invention is further directed to a method for the treatment and / or prevention of diseases, in particular for use in a method for the treatment and / or prevention of cardiovascular, edematous and / or inflammatory disorders, among others. The invention relates to compounds and medicaments comprising said compounds for the treatment and / or prevention of cardiovascular disorders, edematous disorders and / or inflammatory disorders. |